in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—13 November
9:07 AM MST | November 13, 2012 | Deepti Ramesh
EFCG says EU directive does not address API quality issues; calls for mandatory inspection of API manufacturing sites The European Fine Chemicals Group (EFCG; Brussels), an industry association that is part of Cefic, says that thethe European Union's new Falsified Medicines Directive, which is designed to minimize counterfeit medicines entering the EU market, does not adequately address quality issues relating to active pharmaceutical ingredients (API) and does little to improve upon the present directive pertaining to patient safety. EFCG represents over 40 fine...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee